Join to access to all OVN content. Join for Free
People First… Business Second
MSL field team culture interpersonal relationships professional development psychological safety

People First… Business Second


Share This Article


Summary

In this episode, Tom Caravela is joined by Mark Freebery and Rachel Pater to explore the vital role of team culture in the MSL field. They discuss a people-first business philosophy and how fostering the right environment can significantly impact team dynamics. The conversation highlights the influence MSLs have on shaping culture and the importance of recognizing and building individualized connections. The episode delves into assessing cultural fit during interviews and ensuring psychological safety within teams. Additionally, they address balancing personal and professional boundaries and share strategies for professional development, concluding with remarks on the importance of team culture.

Mark Freebery, MSL Regional Director East, and Rachel Pater, Community Medical Liaison Director, West at Syneos Health discuss the importance of investing in people and putting interpersonal relationships first, business second.

Mark and Rachel share…

👉 The importance and benefits of great team culture
👉 Why leaders need to invest in people
👉 What MSLs can do to influence great team culture
👉 Why and how to develop stronger interpersonal relationships
👉 What is “psychological safety” and why is it important
👉 Great examples of professional development programs for MSL teams

Click for Source
MSL field, team culture, interpersonal relationships, professional development, psychological safety

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
It Can be Lonely in the Life of an MSL
Partner Avatar MSL Talk: Tom Caravela, Trish Gorecki

It Can be Lonely in the Life of an MSL

Podcast
What is the ONE Word?
Partner Avatar MSL Talk: Tom Caravela

What is the ONE Word?

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Explore OVN